US Patent 11208432 Inhibitors of glucocorticoid receptor
Patent 11208432 was granted and assigned to ORIC Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+453 characters)
Article
Patent abstract
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer and hypercortisolism.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Daqing Sun0
Haiying Zhou0
John Eksterowicz0
Julio C. Medina0
Lawrence R. McGee0
Liusheng Zhu0
Minna Delarae Balbas0
Valeria R. Fantin0
Xiaohui Du0
Xuelei Yan0
Yosup Rew0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11208432 Inhibitors of glucocorticoid receptor
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11208432
Date of patent
December 28, 2021
Patent application number
16065627
Date Filed
December 22, 2016
Patent primary examiner
Find more entities like US Patent 11208432 Inhibitors of glucocorticoid receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.